TL;DR: Peptide dosage math has three moving parts. Concentration equals peptide mass divided by solvent volume (mg/mL). Volume equals your target dose divided by concentration (mL). On a U-100 insulin syringe, 1 mL always equals 100 units, so units = mL times 100. Change the vial’s water and the units per dose change too.
Understanding peptide dosage is fundamentally an arithmetic problem, not a mysterious one. Once you separate the four quantities involved — peptide mass, solvent volume, concentration, and the dose you want to draw — the confusion usually disappears. This article explains that arithmetic for a research context. It does not recommend doses, protocols, or human use; it explains how the numbers relate so that laboratory measurements are recorded accurately.
The Four Quantities That Matter
Every dosing calculation juggles four values. Keep them straight and the rest follows:
- Peptide mass — how much active peptide is in the vial, usually printed in milligrams (mg).
- Solvent volume — how much bacteriostatic or sterile water was added during reconstitution, in milliliters (mL).
- Concentration — the resulting density of peptide in the liquid, in mg/mL or mcg/mL.
- Target dose — the amount you want to draw for a single measurement, usually in micrograms (mcg).
The single most common error in peptide dosage is mixing up units. A vial labeled “5 mg” contains 5,000 micrograms, because 1 mg = 1,000 mcg. A research dose described as “250 mcg” is therefore 0.25 mg. Getting this factor of 1,000 wrong is the difference between a plausible measurement and one that is off by three orders of magnitude.
mcg vs mg: Why the Distinction Trips People Up
Vials are labeled in milligrams because that is a convenient size for a freeze-dried pellet. Research doses, however, are frequently discussed in micrograms because many peptides are studied at sub-milligram amounts. So the label speaks one language and the protocol speaks another, and you constantly translate between them.
A helpful habit: convert everything to micrograms before you start, do the arithmetic, then convert back only at the end if needed. Working in a single unit removes most slips. If you prefer to skip the manual step entirely, our peptide dosage calculator handles the mg-to-mcg conversion and the volume math in one place.
Concentration: The Number Everything Depends On
Concentration is the bridge between “how much peptide is in the vial” and “how much liquid do I draw.” The formula is simple:
Concentration (mg/mL) = Peptide mass (mg) / Solvent volume (mL)Reconstitute a 5 mg vial with 2 mL of bacteriostatic water and the concentration is 5 / 2 = 2.5 mg/mL, which is the same as 2,500 mcg/mL. Reconstitute the identical 5 mg vial with 1 mL instead and you get 5 mg/mL, or 5,000 mcg/mL — twice as concentrated from the very same powder. The peptide mass never changed; only the water did. This is why two researchers with identical vials can end up drawing completely different volumes for the same target dose.
Because concentration governs everything downstream, it is worth planning solvent volume deliberately rather than by habit. Our reconstitution chart lays out common vial sizes against typical water volumes so you can see the resulting concentrations before you ever pierce a stopper. For the mixing technique itself, the peptide reconstitution guide covers sterile handling step by step.
Converting a Dose to Insulin Units
Most research handling of reconstituted peptides uses U-100 insulin syringes, and this is where “units” enter the picture. The U-100 designation is an international standard: the barrel is calibrated so that 100 units = 1 mL, meaning every single unit equals 0.01 mL, regardless of whether the syringe is a 0.3 mL, 0.5 mL, or 1 mL barrel. The unit is a volume mark, not a peptide amount.
The two-step conversion:
Volume (mL) = Target dose (mcg) / Concentration (mcg/mL)
Insulin units = Volume (mL) x 100Worked example. You have that 2.5 mg/mL solution (2,500 mcg/mL) and want to draw a 250 mcg research dose:
Volume = 250 / 2500 = 0.1 mL
Units = 0.1 x 100 = 10 unitsSo 250 mcg sits at the 10-unit mark.
10 units on a U-100 syringe = 0.10 mL of a 2,500 mcg/mL solution.
Notice that the unit reading is meaningless without the concentration behind it — “10 units” of a weak solution and “10 units” of a strong one contain very different amounts of peptide.
Why Vial Size and Water Volume Change Units Per Dose
This is the confusion the angle of this article most directly targets. Because units are a measure of volume, and volume depends on concentration, the same target dose lands on a different unit mark whenever the concentration changes. The table below holds the target dose fixed at 250 mcg and varies only the reconstitution:
| Vial size | BAC water added | Concentration | Volume for 250 mcg | Insulin units |
|---|---|---|---|---|
| 5 mg | 1 mL | 5,000 mcg/mL | 0.05 mL | 5 units |
| 5 mg | 2 mL | 2,500 mcg/mL | 0.10 mL | 10 units |
| 5 mg | 2.5 mL | 2,000 mcg/mL | 0.125 mL | 12.5 units |
| 10 mg | 2 mL | 5,000 mcg/mL | 0.05 mL | 5 units |
| 10 mg | 4 mL | 2,500 mcg/mL | 0.10 mL | 10 units |
Same target dose, different reconstitutions. The unit reading tracks concentration, not vial size.
Two takeaways. First, a bigger vial does not automatically mean more units per dose — a 10 mg vial in 4 mL gives the exact same concentration, and therefore the same unit reading, as a 5 mg vial in 2 mL. What matters is the mg-to-mL ratio, not the raw vial size. Second, adding more water spreads the same peptide across more volume, pushing each dose onto a higher unit mark. That can be useful: a more dilute solution makes very small research amounts easier to measure precisely, because the dose occupies more of the syringe scale instead of a hard-to-read sliver near zero.
What the Research Shows
The arithmetic above is universal, but it is worth being clear about where the dosing schedules for well-known peptides actually come from. They come from formal clinical trials, not from general rules of thumb — and those figures are specific to the exact molecule, formulation, and population studied.
For semaglutide, the STEP 1 phase 3 trial escalated from 0.24 mg weekly up to a 2.4 mg maintenance dose over 16 weeks, a schedule derived from population pharmacokinetic modeling rather than a fixed ratio (Wilding et al., 2021). Tirzepatide’s SURMOUNT-1 trial similarly used a stepwise escalation across 2.5, 5, 10, and 15 mg weekly arms (Jastreboff et al., 2022). These are human therapeutic trials of finished, regulated drug products; they are cited here to illustrate that real dosing regimens are established through controlled studies and dose-finding pharmacokinetics, not extrapolated from vial arithmetic.
Much of the broader peptide literature, by contrast, remains preclinical — cell culture and animal models — with human data limited or absent for many research compounds. More than 80 peptide drugs have reached regulated markets over the past century, but that leaves a large field of peptides studied only in early or non-human settings (Muttenthaler et al., 2021). The math in this guide tells you what is in a given volume; it says nothing about what any amount does in a living system, which is a separate, evidence-dependent question.
Practical Sources of Error
A few recurring pitfalls, all arithmetic rather than biological:
- Assuming the label is the dose. A “5 mg vial” is the total peptide, not a single measurement. You still divide it across many draws.
- Ignoring dead space. A small residual volume stays in the syringe hub after the plunger is fully depressed. Low-dead-space insulin syringes minimize this, but it is a real source of variance at tiny volumes (Frid et al., 2016).
- Reading the wrong barrel. A 0.3 mL and a 1 mL syringe both use the 100-units-per-mL scale, but the tick spacing differs. Confirm which barrel you are reading.
- Forgetting the preservative context. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, which is what allows multiple withdrawals; sterile water does not (DailyMed, USP label).
When you are comparing vial sizes to plan a purchase, remember that a larger vial is not inherently better value once you account for the concentration you actually want — the peptide price index helps compare cost per mg across sizes so the dosing math and the budget line up.
Frequently Asked Questions
How do I convert peptide mcg to insulin units?
First find your concentration in mcg/mL (peptide mcg divided by water mL). Divide your target dose in mcg by that concentration to get volume in mL, then multiply by 100. Example: 250 mcg from a 2,500 mcg/mL solution is 0.1 mL, which is 10 units on a U-100 syringe.
Does a bigger vial mean more units per dose?
Not necessarily. Units per dose depend on concentration, which is the mg-to-mL ratio, not the raw vial size. A 10 mg vial reconstituted with 4 mL has the same concentration as a 5 mg vial with 2 mL, so the same target dose reads at the same unit mark on both.
What does U-100 mean on an insulin syringe?
U-100 is an international calibration standard meaning the barrel is marked for a fluid containing 100 units per milliliter. Practically, 1 mL equals 100 units and each unit equals 0.01 mL, on every U-100 syringe regardless of whether it holds 0.3, 0.5, or 1 mL.
Why does adding more water change my dose reading?
Adding more solvent spreads the same fixed peptide mass across a larger volume, lowering the concentration. A lower concentration means any given dose occupies more milliliters, so it lands on a higher unit mark. The peptide amount is unchanged; only the volume it is dissolved in has grown.
Is 1 mg the same as 1000 mcg?
Yes. One milligram equals exactly 1,000 micrograms. This factor of 1,000 is the most common source of peptide dosage errors, so converting your whole calculation into a single unit before you begin is the simplest way to avoid a hundredfold or thousandfold mistake.
Should I use more or less water for small research doses?
More dilute solutions place a small dose across more of the syringe scale, which can improve measurement precision because the meniscus sits at a clearly readable mark rather than a sliver near zero. The trade-off is a larger injection volume. The reconstitution chart shows how each choice shifts the numbers.
References
- Muttenthaler M, King GF, Adams DJ, Alewood PF. Trends in peptide drug discovery. Nature Reviews Drug Discovery. 2021;20(4):309-325. doi:10.1038/s41573-020-00135-8
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
- Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism. 2021;46:101102. doi:10.1016/j.molmet.2020.101102
- Frid AH, Kreugel G, Grassi G, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231-1255. doi:10.1016/j.mayocp.2016.06.010
- Bacteriostatic Water for Injection, USP [package insert]. Hospira/Pfizer. DailyMed, U.S. National Library of Medicine. Accessed 2026.
Research use only. This article explains dosing arithmetic for laboratory and educational contexts. It is not medical advice and does not recommend any dose, protocol, or human use. Peptides discussed here are not approved for self-administration; handle all research materials in accordance with applicable regulations and institutional guidance.